Podcasts about hiv prevention

In episode 49 of Going anti-Viral, Dr Judith Currier joins host Dr Michael Saag to discuss Next-Gen HIV Prevention and Treatment. Dr Currier is a Professor of Medicine at UCLA and has more than 25 years of experience in the design, implementation, conduct, and analysis of clinical trials to optimize antiretroviral management of HIV and related complications. Dr Currier and Dr Saag provide an overview of why new antiretroviral drugs are needed and discuss the successful return on investment in biomedical research. They also provide a detailed review of long-acting antiretroviral drugs and discuss the state of current research for new options, including a discussion of lenacapavir. Finally, they share their concerns for what is at stake if attempts to cut the federal research budget are successful and the disruption it will bring to the progress that has been made in HIV care and other viral diseases.  0:00 – Introduction1:20 – Overview of why new antiretroviral drugs are needed2:57 – The return on investment in biomedical research3:52 – Overview of the need for long-acting antiretroviral drugs and options available 8:23 – Review of the current research and prospects for new long-acting therapies 12:59– Discussion of lenacapavir and the potential benefits for prevention and treatment 14:21 – Summary of other drugs on the horizon that may be potential treatments18:39 – Overview of the different methods for delivery of drugs21:11 – Impact of potential budget cuts on HIV research, on people with HIV, and on other viral diseases __________________________________________________Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections. Going anti-Viral's host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences. Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode.Follow Going anti-Viral on: Apple Podcasts YouTubeXFacebookInstagram...

In this episode, Dr. June Gipson, CEO of My Brother's Keeper, Inc., joins the podcast to share how her organization is addressing sexual and reproductive health, tackling funding cuts, and expanding care across Mississippi. She also discusses emerging public health trends, the power of prevention, and how leaders must adapt to sustain impact in fragile systems.

Be proactive in managing drug–drug interactions in patients on long-acting injectables (LAIs) for HIV prevention and treatment. Credit available for this activity expires: 5/22/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/maximizing-success-hiv-prevention-and-treatment-reframing-2025a1000cm3?ecd=bdc_podcast_libsyn_mscpedu

The National Weather Service issues a heat advisory for LA County. Latino lawmakers are not going to accept Governor Newsom's budget without a fight. LA's HIV prevention experts fear the worst from federal funding cuts. Plus more.Support The L.A. Report by donating at LAist.com/join and by visiting https://laist.comVisit www.preppi.com/LAist to receive a FREE Preppi Emergency Kit (with any purchase over $100) and be prepared for the next wildfire, earthquake or emergency! Support the show: https://laist.com

Scientific researchers in Rhode Island are reeling from canceled grants and other potential cuts to federal funding for their work. Globe Rhode Island's Steph Machado just finished a story for Rhode Island PBS Weekly about the effects of these cuts. She joins host Ed Fitzpatrick to talk about what she learned. Tips and ideas? Email us at rinews@globe.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Mitchell Warren, AVAC's Executive Director, joins Ben to scope out a forward-looking infectious disease   prevention strategy. It is urgently needed, amidst political and economic turmoil caused by the dismantling of US aid and declines in funding from European donors. With HIV as the poster child of what once was global health solidarity, it is an opportunity for a resurgent and resilient Global South to take the reins and set priorities in how to deploy new biomedical innovations, and protecting the rights of communities affected by HIV and other pandemics. Ben and Mitchell also delve into the various legal actions the public health community is taking against the current US administration's executive orders, asking the question - how to we prep for prevention at home and internationally?  00:00 Introduction and Current Challenges in Global Health  01:09 Welcoming Mitchell Warren and AVAC's Mission  01:43 The Evolution of HIV Prevention and AVAC's Role  03:17 Current Frustrations and Challenges in HIV Prevention  05:15 The Promise and Challenges of Lenacapavir  08:03 The Importance of Choice in HIV Prevention  10:22 Navigating Funding and Policy Obstacles  12:43 The Role of Donors and Ministries in HIV Prevention  14:56 The Urgency of Lenacapavir Approval and Implementation  20:52 Sustainability and Future Planning in Global Health  25:44 Legal Battle Against Government Orders  26:50 Temporary Restraining Order and Its Implications  27:14 Government's Slow Compliance and Ongoing Legal Struggles  28:38 Public Record and Whistleblower Revelations  30:56 Impact on American Influence and Global Health  33:45 Diplomacy and Foreign Assistance  35:04 Consequences of Policy Changes  40:01 Future Strategies and Targets for Global Health  45:51 Music and Reflections on Democracy  48:21 Conclusion and Final Thoughts  Learn more about AVAC https://avac.org  

On Tuesday's show: A challenge on religious grounds to a requirement that health insurance providers cover HIV prevention medications was heard at the U.S. Supreme Court on Monday. Legal expert Seth Chandler explains the case, which stemmed from Texas.Also this hour: Houston has higher rates of sexually transmitted infections compared to the rest of Texas, according to Harris County Public Health. We discuss how local public health professionals are fighting STIs and misinformation.Then, on this Earth Day, we revisit a 2022 conversation with Rice University historian Douglas Brinkley about how one book sparked the great environmental awakening of the 1960s and 70s.And we talk with musician and Houston native David Ramirez, who's performing Wednesday at The Heights Theater.

Last month, President Donald Trump's administration slashed funding for the CDC's HIV prevention programs. Administrators of similar programs in Louisiana — which has one of the highest rates of HIV per capita of any U.S. state — are bracing for the loss of federal grants too. Public health reporter Rosemary Westwood tells us what they're doing to prepare for the loss of funding.Also at the direction of the Trump administration, the National Endowment for the Humanities this month abruptly cancelled millions of dollars in disbursements for grants that had already been awarded. The NEH helps fund museums, archives, literary festivals, historic preservation and more.A little less than half of NEH funds go directly to state-level endowments, like the Louisiana Endowment for the Humanities. LEH Executive Director and President Miranda Restovic discusses what these cuts mean for Louisiana.A new technology competition is coming to Baton Rouge this June. The Nexus Technology Cup will award more than $100,000 to aspiring inventors and entrepreneurs. Tony Zanders, CEO of Nexus Louisiana, joins us for more on the competition.—Today's episode of Louisiana Considered was hosted by Adam Vos. Our managing producer is Alana Schreiber. We get production support from Garrett Pittman and our assistant producer Aubry Procell.You can listen to Louisiana Considered Monday through Friday at noon and 7 p.m. It's available on Spotify, the NPR App and wherever you get your podcasts. Louisiana Considered wants to hear from you!Please fill out our pitch line to let us know what kinds of story ideas you have for our show. And while you're at it, fill out our listener survey! We want to keep bringing you the kinds of conversations you'd like to listen to.Louisiana Considered is made possible with support from our listeners. Thank you!

EASY LISTENING DEP'T.

John Maytham speaks with Mia Malan about a game-changing development in HIV prevention: lenacapavir, the six-monthly injectable. A recent modelling study reveals that if South Africa’s health department can secure the drug at a price between R2 238 and R4 304 per person annually, it could be a cost-effective and transformative addition to the country's HIV response.See omnystudio.com/listener for privacy information.

RaeAnn Tucker from the Henry and Stark County Health Departments joined Wake Up Tri-Counties to discuss National Public Health Week, Cancer Control Month, and HIV Prevention Programs. As National Public Health Week 2025 commences, the Henry and Stark County Health Departments celebrate three decades of dedicated service, underscoring the theme “30 Years—Public Health Week It Starts Here.” With a focus on prevention and health equity, efforts are pursued to foster healthier communities. April also marks Cancer Control Month, encouraging lifestyle changes to reduce cancer risks. Additionally, National Youth HIV/AIDS Day highlights crucial PrEP/HIV prevention programs available in Kewanee, Colona, and Toulon. This comprehensive initiative offers education, testing, and affordable treatment, contributing to the well-being of the community. For more details, contact the Henry & Stark Health Departments.

Come celebrate 5 years of Bad Queers!  We're throwing down all month long with virtual events and an in-person celebration in Chicago. Don't miss the chance to connect and toast to five years of this podcast. This week, we unpack major headlines—from the CDC's sudden shutdown of key HIV prevention initiatives to Cory Booker's record-breaking filibuster speech. Plus, a win for the LGBTQ+ community: country artist Tanner Adell comes out as pansexual at the Billboard Women in Music Awards. In our advice segment, Am I a Bad Queer?, we dig into: - Is having a “backup bae” while in a relationship ever okay? - Coming out and feeling like a queer newbie - Going back in the closet to safely explore sexuality For Bad Queer Opinions, we're talking: Why we need to celebrate positive masculine traits The hard truth: not everyone in the LGBTQ+ community is a safe space Shoutouts: Kris: Shaundel Washington-Spivey - elected first Black and LGBTQ mayor of La Crosse Wis. on Tuesday Washington-Spivey is a former elected school board member and community leader who co-founded Black Leaders Acquiring Collective Knowledge (B.L.A.C.K.), Inc., a nonprofit organization that supports La Crosse youth through various programs and initiatives. Shana: Be Steadwell - Author of Chocolate Chip City - Black women and queer people are at the center. It's got magic, hot sexy scenes, and is grounded in spirit, resistance and dreams. Imagine what DC would look like if we all stepped in our power. Coming out June 3rd - Follow on IG @besteadwell Episode Notes: 1:16 - Queer Urban Dictionary - AMAB and TINA5:12 - 5 Years of Bad Queers: Join us for in person and virtual events10:41 - HIV Prevention Offices Shut Down at CDC 13:19 - Good Trouble: Cory Booker breaks a 68-year-old Senate record with a 25-hour speech18:06 - Tanner Adell Comes Out as Pansexual 21:30 - Am I a Bad Queer? Advice Segment 36:11 - Bad Queer Opinions46:38 - ShoutoutsShare your Am I A Bad Queer? hereSupport the showWe are on Patreon!! patreon.com/BadQueersPodcast Subscribe to our Youtubehttps://www.youtube.com/@BadQueersPodcastSend your Am I A Bad Queer questions to us on our website at https://badqueers.com/ or at badqueers@badqueers.com Follow us @badqueerspod on Twitter, Facebook, Instagram & Tik TokOpening song by Siena Liggins: @sienaligginsLike us? Love us? Leave a review The opinions expressed during this podcast are conversational in nature and expressed only for comedic purposes. Not all of the facts will be correct but we attempt to be as accurate as possible. BQ Media LLC, the hosts, nor any guest host(s) hold no liability over the conversations on this podcast and by using this podcast you understand that it is solely for entertainment purposes. Copyright Disclaimer: Under Section 107 of the Copyright Act 1976, allowance is made for "fair use" for purposes such as criticism, comment, news reporting, teaching, parody, scholarship and research.

Our lead story: Prime Minister Mark Carney pauses his campaign to respond to U.S. President Donald Trump's new global, "liberation day" tariffs, informing Canadians “times will be tough… now that the U.S. is no longer a reliable trade partner.” . . . . . . .  Interstitial: zapsplat.com

Advocates say Milwaukee could lose over $1 million in federal funding for HIV testing, prevention and treatment if the proposed cuts CDC's Division of HIV happen.

The crew, including Brogan, returns to chat about HIV Prevention monsters, who would win in a fistfight between Baton Rouge and Tacoma, gas prices, the world's largest convenience store, Austin, Texas, future meet-ups, bridges, Shrimp Po Boy sandwiches, and much, much more! 01:45 – The guys talk about how long it's been since they've chatted, Brogan talks about what area in Louisiana he's at, and the amazing bars that are in his area. He gives a shout-out to Joe at Zee Zees, discusses his new job, and his sighting of his first outdoor cockroach. Jeff talks about what made The Villages in Florida famous, dreams of moving there minus one limitation, and Brogan talks about Louisiana's stance on legalizing Marijuana. 16:24 – They discuss the importance of proper punctuation in advertising, who represents the gangster in the billboard, and Brogan talks about a sign in the area that encourages people to throw bottles at it. They discuss ideas to incentivize the sign, and Brogan declares who would win in a fistfight between Baton Rouge and Tacoma. 31:02 – Brogan shares why people should check out The Thing when cruising through eastern Arizona, Jeff talks about it being his first roadside attraction, and they both express the good vibe that the place gives off. Brogan expresses his love of Austin, Texas and talks about Baton Rouge having one of the highest murder rates in the country. 44:07 – Scott discusses his recent visit to Northwest Trek with his wife, the guys make plans to visit Brogan in Baton Rouge, and Scott talks about how much he enjoyed the recent GCP meet-up at The Berliner Beerhall. Jeff reflects on the conversation at the Camp Bar, Brogan speaks of Louisiana's southern hospitality, and Jeff shares ideas for future GCP meet-ups.

The Trump administration may eliminate the Division of HIV Prevention within the CDC, along with $1.3 billion in funding.See omnystudio.com/listener for privacy information.

Welcome to The Monday Edit! This is the official Getting Better companion podcast where JVN and senior producer Chris are diving into all things BTS from the pod, answering listener questions, and breaking down the world at large. This week, we're talking: astrological sister signs, the ongoing Bhad Bhabie & Alabama Barker feud, the great Cybertruck recall of 2025, and the recent attacks on the HIV social safety net. We're giving you laughs and learning over here - plus: Full video episodes now on YouTube every Monday!  Follow us on Instagram @gettingbetterwithjvn Jonathan on Instagram @jvn and senior producer Chris @amomentlikechris New video episodes of Getting Better on YouTube every Wednesday. Our Senior Producer is Chris McClure. Our editor & engineer is Nathanael McClure. Our theme music is also composed by Nathanael McClure. Production support from Julie Carrillo, Anne Currie, and Chad Hall. Curious about bringing your brand to life on the show? Email podcastadsales@sonymusic.com. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Lester Kiewit speaks to Professor Linda-Gail Bekker of the Desmond Tutu Health Foundation discussed the FAST PrEP mobile clinics providing HIV prevention services at 16 Cape Town schools. She highlighted how the initiative offers PrEP, contraceptives, and STI services to students aged 15 and older, with support from the Western Cape Department of Education to ensure access without disrupting school activities.See omnystudio.com/listener for privacy information.

The latest episode of The Top Line, sponsored by ViiV Healthcare, features Dr. Luis Buzón, an infectious disease specialist, discussing the critical role of real-world evidence in HIV treatment and prevention. While clinical trials establish the safety and efficacy of new therapies, real-world data help bridge the gap between these highly controlled environments and patient care in the real world. Buzón explains that collecting long-term data is essential, especially for lifelong conditions like HIV. Not only do real-world studies track how medicines perform over longer periods of time than clinical trials, they include a broader range of people, revealing potential side effects not seen in trials and ensuring long-term effectiveness for the different people who can be impacted by HIV. Beyond the science, Buzón shares how his father was a pioneer in Spain’s early response to the HIV epidemic, and why, inspired by his father’s dedication, he continues to advocate for compassionate, evidence-based care. For those interested in the evolving landscape of HIV treatment and prevention and the power of real-world data in shaping better health outcomes, this episode is a must-listen. Tune in to The Top Line to hear Buzón’s expert insights and personal perspective.See omnystudio.com/listener for privacy information.

A Routine STI Check. A Life-Changing Diagnosis. At 21, Ellie Harrison was living her London dream; working in fashion, in a long-term relationship, studying and partying with friends. Then a routine STI check changed everything: she was HIV positive. Her diagnosis was a complete mystery, and in that moment it felt like the sky was falling. Sitting alone on a canal-side bench after leaving the clinic, Ellie was convinced she'd just been handed a death sentence. In this conversation you’ll hear: What happened after her diagnosis What it really means to live with HIV today The key differences between HIV and AIDS The stigma and prejudice she’s faced Her mission to help end HIV transmission Ellie tells a powerful story of resilience, enlightenment and breaking down outdated misconceptions. You can read more about the work of the UK charity, Terrence Higgins Trust here. THE END BITS: Listen to more No Filter interviews here and follow us on Instagram here. Discover more Mamamia podcasts here. Feedback: podcast@mamamia.com.au Share your story, feedback, or dilemma! Send us a voice message, and one of our Podcast Producers will get back to you ASAP. Rate or review us on Apple by clicking on the three dots in the top right-hand corner, click Go To Show then scroll down to the bottom of the page, click on the stars at the bottom and write a review CREDITS: Host: Kate Langbroek Guest: Ellie Harrison. Executive Producer: Naima Brown Senior Producer: Grace Rouvray Audio Producer: Jacob Round Mamamia acknowledges the Traditional Owners of the Land we have recorded this podcast on, the Gadigal people of the Eora Nation. We pay our respects to their Elders past and present, and extend that respect to all Aboriginal and Torres Strait Islander cultures.Become a Mamamia subscriber: https://www.mamamia.com.au/subscribeSee omnystudio.com/listener for privacy information.

Check out a compilation of three previous episodes on pleasure. After you hear what each of our guests has to share, take a listen to one (or all!) of the full episodes:  Dan Savage on the Magic Question “What are you into?” & Dr. Ina Park on How Providers can Help   Intimacy Starts with I: Women, Self-Love, and HIV with Michelle Lopez  From Red Ribbons to Leather Straps: Rodney McCoy's Trailblazing Tale of HIV Prevention and Pleasure  Have any questions, concerns, or love letters? Send us a message on Instagram @comingtogetherpod or email us at captc@ucsf.edu  Don't forget to leave us a review on Spotify, or wherever you get your podcasts. 

In this week's HLbytes Roundup, host Andy Demetriou discusses the byte “District Court Orders Federal Agencies to Restore Access to Resources for HIV Prevention and Contraceptives” submitted by Sam Ruddy and Caitlin Forsyth and more. For more on these stories and others like it, go to ambar.org/hlsnews and check your inbox every Wednesday for the next edition of HLbytes.

The Fight for HIV Prevention & Treatment in Georgia. Join us for an insightful roundtable discussion with Rebecca Grapevine, a public health journalist at KFF Health News, as we dive deep into her latest article: Biden Rule Cleared Hurdles to Life-Saving HIV Drugs, but in Georgia Barriers Remain.

Monica Gandhi, MD, reflects on her decades-long work in HIV care, from providing care early in the epidemic to leading implementation of today's groundbreaking medical advances. She discusses the science behind HIV (including how 7 people have been cured), the groundbreaking shift from complex pill regimes to long-acting injectable therapies, and how these innovations help patients facing medication challenges. Monica also draws parallels to COVID-19 as she underscores the importance of harm reduction; encourages bipartisan support while talking about policy and funding; addresses social determinants of health that impact HIV prevention and treatment. For her, HIV is not just an infection, but a movement driving healthcare and equity forward.  Read the transcript of the episode. Connect with Dr. Monica Gandhi on Twitter and LinkedIn  Endemic, by Monica Gandhi  CAPTC HIV & PrEP Resources  Long-Acting Injectable PrEP  Previous episode with Dr. Monica Gandhi: S1 E7: How Effective Are COVID-19 Vaccines? with Dr. Monica Gandhi  Monica Gandhi, MD, MPH, is a Professor of Medicine and an Associate Chief in the Division of HIV, Infectious Diseases, and Global Medicine at the University of California, San Francisco. She is the director of the UCSF Center for AIDS Research and the Medical Director of the HIV clinic (Ward 86) at SF General Hospital. Dr. Gandhi also serves as the Associate Program Director of the Infectious Diseases Fellowship at UCSF. Her research focuses on HIV treatment and prevention optimization, HIV in women, adherence measurements in HIV and tuberculosis, adherence interventions, and optimizing the use of long-acting antiretroviral therapy. Dr. Gandhi has been in the HIV workforce since 1996 and brings an extremely important level of expertise to the field. Her book, Endemic, illustrates the lessons to be learned and applied to future epidemics from the HIV epidemic.   Have any questions, concerns, or love letters? Send us a message on Instagram @comingtogetherpod or email us at captc@ucsf.edu  Don't forget to leave us a review on Spotify, or wherever you get your podcasts.  

To connect with Dominick: LinkedIn: Dominick Shattuck, PhDJohns Hopkins: Bloomberg School of Public HealthMale Engagement Task Force To connect with Travis:https://www.travisstock.com/IG: @travers03Patreon: https://www.patreon.com/c/thenewmasculine

We're experimenting and would love to hear from you!In this episode of Discover Daily, we explore groundbreaking technological and scientific developments shaping our future. MIT's revolutionary DrivAerNet++ database takes center stage, featuring over 8,000 AI-generated electric vehicle designs with comprehensive aerodynamic data, promising to transform automotive development processes and accelerate EV innovation.The show delves into a major medical breakthrough as lenacapavir, Science magazine's 2024 Breakthrough of the Year, emerges as a game-changing HIV prevention drug. This remarkable innovation from Gilead Sciences offers six months of protection with a single injection, demonstrating 96-100% efficacy in clinical trials and holding promise for global HIV prevention efforts.The episode's main focus spotlights DeepSeek-V3, a cutting-edge open-source AI model boasting 671 billion parameters. Using innovative Mixture-of-Experts architecture, this powerful language model activates only 37 billion parameters per token, achieving impressive efficiency while maintaining high performance across various text-based tasks. The discussion explores its capabilities, limitations, and potential impact on the AI landscape.From Perplexity's Discover Feed:https://www.perplexity.ai/page/mit-s-ev-design-database-HW3LeM4gQNO2pa1oYp6AMwhttps://www.perplexity.ai/page/hiv-drug-named-breakthrough-of-kzPk2YAoQPKS.CdzOsNdXAhttps://www.perplexity.ai/page/deepseek-s-new-open-source-ai-YwAwjp_IQKiAJ2l1qFhN9gPerplexity is the fastest and most powerful way to search the web. Perplexity crawls the web and curates the most relevant and up-to-date sources (from academic papers to Reddit threads) to create the perfect response to any question or topic you're interested in. Take the world's knowledge with you anywhere. Available on iOS and Android Join our growing Discord community for the latest updates and exclusive content. Follow us on: Instagram Threads X (Twitter) YouTube Linkedin

We are back with more exciting IDWeek 2024 content. In this episode, Breakpoints hostesses Drs. Erin McCreary, Julie Ann Justo, Jeannette Bouchard, and Megan Klatt highlight more of our favorite sessions and posters at IDWeek, this episode is a must listen if you are an IDWeek nerd like us! References: Perret et al. Application of OpenAI GPT-4 for the retrospective detection of catheter-associated urinary tract infections in a fictitious and curated patient data set. 10.1017/ice.2023.189 Wiemken et al. Assisting the infection preventionist: Use of artificial intelligence for health care–associated infection surveillance. 10.1016/j.ajic.2024.02.007 Leekha et al. Evaluation of hospital-onset bacteraemia and fungaemia in the USA as a potential healthcare quality measure: a cross-sectional study. 10.1136/bmjqs-2023-016831 Diekema et al. Are Contact Precautions "Essential" for the Prevention of Healthcare-associated Methicillin-Resistant Staphylococcus aureus? 10.1093/cid/ciad571 Martin et al. Contact precautions for MRSA and VRE: where are we now? A survey of the Society for Healthcare Epidemiology of America Research Network. 10.1017/ash.2024.350 Browne et al. Investigating the effect of enhanced cleaning and disinfection of shared medical equipment on health-care-associated infections in Australia (CLEEN): a stepped-wedge, cluster randomised, controlled trial. 10.1016/S1473-3099(24)00399-2 Protect trial: Decolonization in Nursing Homes to Prevent Infection and Hospitalization. 10.1056/NEJMoa2215254 Aldardeer et al. Early Versus Late Antipseudomonal β-Lactam Antibiotic Dose Adjustment in Critically Ill Sepsis Patients With Acute Kidney Injury: A Prospective Observational Cohort Study. 10.1093/ofid/ofae059 Schmiemann et al. Effects of a multimodal intervention in primary care to reduce second line antibiotic prescriptions for urinary tract infections in women: parallel, cluster randomised, controlled trial. 10.1136/bmj-2023-076305 Vernacchio et al. Improving Short Course Treatment of Pediatric Infections: A Randomized Quality Improvement Trial. 10.1542/peds.2023-063691 Advani et al. Bacteremia From a Presumed Urinary Source in Hospitalized Adults With Asymptomatic Bacteriuria. 10.1001/jamanetworkopen.2024.2283 Saif et al. Clinical decision support for gastrointestinal panel testing. 10.1017/ash.2024.15 Bekker et al. Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women. 10.1056/NEJMoa2407001 Montini et al. Short Oral Antibiotic Therapy for Pediatric Febrile Urinary Tract Infections: A Randomized Trial. 10.1542/peds.2023-062598 Nielsen et al. Oral versus intravenous empirical antibiotics in children and adolescents with uncomplicated bone and joint infections: a nationwide, randomised, controlled, non-inferiority trial in Denmark. 10.1016/S2352-4642(24)00133-0 Kaasch et al. Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial. 10.1016/S1473-3099(23)00756-9 AMIKINHAL: Inhaled Amikacin to Prevent Ventilator-Associated Pneumonia. 10.1056/NEJMoa2310307 PROPHY-VAP: Ceftriaxone to prevent early ventilator-associated pneumonia in patients with acute brain injury: a multicentre, randomised, double-blind, placebo-controlled, assessor-masked superiority trial. 10.1016/S2213-2600(23)00471-X AVENIR: Azithromycin to Reduce Mortality — An Adaptive Cluster-Randomized Trial. 10.1056/NEJMoa2312093 Thomas et al. Comparison of Two High-Dose Versus Two Standard-Dose Influenza Vaccines in Adult Allogeneic Hematopoietic Cell Transplant Recipients. 10.1093/cid/ciad458 Schuster et al. The Durability of Antibody Responses of Two Doses of High-Dose Relative to Two Doses of Standard-Dose Inactivated Influenza Vaccine in Pediatric Hematopoietic Cell Transplant Recipients: A Multi-Center Randomized Controlled Trial. 10.1093/cid/ciad534 Mahadeo et al. Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): a phase 3, multicentre, open-label trial. 10.1016/S1470-2045(23)00649-6 Khoury et al. Third-party virus-specific T cells for the treatment of double-stranded DNA viral reactivation and posttransplant lymphoproliferative disease after solid organ transplant. 10.1016/j.ajt.2024.04.009 Spec et al. MSG-15: Super-Bioavailability Itraconazole Versus Conventional Itraconazole in the Treatment of Endemic Mycoses—A Multicenter, Open-Label, Randomized Comparative Trial. 10.1093/ofid/ofae010

Abdul and Katelyn talk about a promising bipartisan bill that could disrupt Pharmacy Benefit Managers, a miracle drug that prevents HIV--at a serious cost, and new data that show that US obesity rates may have fallen for the first time in more than a decade. Then they talk about RFK Jr's chances of being confirmed to lead HHS after news broke last week that his attorney asked the FDA to repeal approval of the polio vaccine back in 2022. Then Abdul sits down with Dr. Umair Shah, Washington State's Secretary of Health, about the role of state health departments over the next four years. We will be back with more episodes in 2025. We wish you all a restful holiday season!  This show would not be possible without the generous support of our sponsors. America Dissected invites you to check them out. This episode was brought to you by: Marguerite Casey Foundation: Sign up now to get your free Boston Review issue delivered to your door at CaseyGrants.org/State. Calm: Calm is offering an exclusive offer of 40% off a Calm Premium Subscription at calm.com/DISSECT. Lumen: If you want to stay on track with your health this holiday season, head to http://lumen.me/AD for 15% off your purchase. Reclaimed: This podcast takes you back to the very beginning when the Navajo reservation was first created. And it reveals the history of oppression and exclusion that led the Navajo to this point — and why their future is still uncertain. You can listen to “Reclaimed” wherever you get podcasts.

A Shot in the Arm Podcast is proud to bring you another installment of Global Health Diplomats! In this compelling episode, co-hosts Ben Plumley and Eric Goosby dive deep into the future trajectory of the global HIV response. Following World AIDS Day, the discussion spans a 38,000-foot view of where the HIV epidemic stands, its critical challenges, and the evolving strategies needed for a sustainable, long-term response. From the impact of geopolitical shifts on access to treatment and care to the integration of HIV programs with broader primary healthcare systems, this episode unpacks the most pressing issues in global health today. Key Highlights: HIV Goals for 2030: Reality Check Are we close to ending AIDS as a public health crisis? Dr. Eric Goosby reflects on the progress made and the significant hurdles ahead. Quote: "We've built breathtaking infrastructure over 25 years, but it's clear we won't cross the 2030 finish line without major shifts." (Eric Goosby, 00:01:24) The Role of Targets in the HIV Response Are political targets still relevant in today's complex world? Ben and Eric debate the pros and cons of target-driven approaches in global health. Quote: "Targets have driven investment and expanded care, but we may need to rethink them in light of new challenges." (Eric Goosby, 00:05:26) Primary Care Integration Why the HIV response must pivot toward integrated primary healthcare to address non-communicable diseases and pandemic preparedness. Quote: "For people living with HIV, coronary artery disease, hypertension, and cancer are now the bigger threats. Primary care is key." (Eric Goosby, 00:07:46) The Geopolitical Impact on HIV Care Rising anti-rights movements and geopolitical challenges make it harder to bring marginalized populations into care. Quote: "The rights-based approach to care is under siege globally, making access for key populations even tougher." (Ben Plumley, 00:10:04) Funding Sustainability Beyond 2030 Exploring innovative funding mechanisms, domestic ownership, and the evolving role of multilateral agencies like the Global Fund. Quote: "Transitioning to country-driven funding is essential. It's time for governments to take ownership." (Eric Goosby, 00:30:01) HIV Prevention's Urgent Need for Innovation Despite treatment advancements, global prevention efforts lag behind, especially for at-risk populations. Quote: "Prevention needs to focus on behavior, access, and new technologies like PrEP for real impact." (Eric Goosby, 00:37:26) Upcoming Episodes in the Series: Rights-Based Approaches in HIV Care Funding the Future: Domestic Resource Mobilization for HIV Programs Prevention Innovation: From Behavioral Change to Biomedical Solutions Reimagining Global Health Architecture Post-2030 Acknowledgments: This podcast is made possible by the generous support of the John T. Martin Foundation. Produced by Erik Espera of NewsDoc Media. Subscribe and Share: Stay tuned for more in-depth discussions on the future of global health. Subscribe to Global Health Diplomats wherever you download podcasts, and leave us a five-star review to support the conversation! Share your thoughts and join the discussion on social media using #GlobalHealthDiplomats and #WorldAIDSDay2024!

This episode discusses six MMWR reports. First, three reports describe the spread of parvovirus B19 in the United States in 2024; some groups are at increased risk for serious complications from this infection. Second, emergency department visits for firearm injuries declined from 2022 to 2023 yet were still higher than before the pandemic. Third, Rocky Mountain spotted fever continues to emerge in the California-Mexico border region. Last, CDC makes progress toward ending HIV as a public health threat by reaching more than 2 million people in 37 countries with pre-exposure prophylaxis, or PrEP.

Welcome to this month's episode of Public Health Musings! In this episode, we explore "HIV Prevention in the Black Community, especially Heterosexual Women," featuring Grazelle Howard from the Black AIDS Institute. Grazelle shares her expertise on the critical need for targeted HIV prevention strategies and the role of community engagement in combating the epidemic. Don't miss this informative discussion—tune in now!

Die Themen in den Wissensnachrichten +++ Unerwartete Hitze-Hotspots nehmen weltweit zu, besonders in Europa +++ Eine Spritze schützt sechs Monate vor HIV +++ Vier von zehn Lehramtsstudierenden brechen ab +++**********Weiterführende Quellen zu dieser Folge:Global emergence of regional heatwave hotspots outpaces climate model simulations, PNAS, 26.11.2024Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons, NEJM, 27.11.2024Lehrkräftetrichter im Ländervergleich, Stifterverband für die Deutsche Wissenschaft e.V., 28.11.2024Culinary Medicine Cooking Workshops as Add-On Therapy for Inpatients with Depression and Eating Disorders, Nutrients, 20.11.2024The Fischer-Lactonization-Driven Mechanism for Ultra-Efficient Recycling of Spent Lithium-Ion Batteries, Angewandte Chemie, 12.10.2024Alle Quellen findet ihr hier.**********Ihr könnt uns auch auf diesen Kanälen folgen: TikTok auf&ab , TikTok wie_geht und Instagram .

In the days and years ahead under a Trump Administration, advocacy for choice, freedom, science, and rights will require deep strategic shifts to protect hard-fought gains in global health generally, and to safeguard policies and programs that advance it. And there will be major implications for the global AIDS response. Joining us to navigate all this and to better understand the landscape for advocacy are Jen Kates from KFF, a nonpartisan health policy research organization, and our own Suraj Madoori.     

Join Marla Dalton, PE, CAE, and William Schaffner, MD, for an inspiring conversation with Demetre C. Daskalakis, MD, MPH, director of the National Center for Immunization and Respiratory Diseases (NCIRD) at the Centers for Disease Control and Prevention (CDC). He shares his journey from HIV clinical practice to public health leadership, demonstrating his relentless passion and commitment to health equity, clear and transparent communication, and ensuring equitable access to vaccines for all children and adults. Show notesDaskalakis leads CDC efforts to detect, prevent, and respond to vaccine-preventable and respiratory infectious disease threats. He began his career at Bellevue Hospital in New York, where he spearheaded HIV testing and prevention programs. As deputy commissioner for the Division of Disease Control at the NYC Department of Health and Mental Hygiene, he directed public health programs on HIV, tuberculosis, sexually transmitted infections, and vaccine-preventable diseases, and earned a national reputation as an activist and advocate for at-risk populations. He also served as the NYC incident commander during the measles outbreak in 2019 and the COVID-19 pandemic in 2020. He joined CDC in 2021 as director of the Division of HIV Prevention and served as deputy coordinator of the White House Mpox Response.

The promise of long-acting PrEP has been super-charged this year by studies showing the powerful efficacy of an antiretroviral known as lenacapavir (LEN).  This episode of PxPulse goes deep on LEN for PrEP. Recorded just days before Gilead's announcement that PURPOSE 2 also found very high efficacy, Dr. Flavia Kiweewa, a principal investigator of PURPOSE 1, the first trial to announce efficacy, lays out the research findings and what they mean. And Chilufya Kasanda Hampongo of Zambia's Treatment Advocacy and Literacy Campaign and Mitchell Warren of AVAC talk about how to change a long history of squandered opportunities to get rollout right.  The PURPOSE1 trials announced findings in June that a twice-yearly injection of LEN was 100% effective among cisgender women, with zero new cases of HIV. And the PURPOSE 2 trial among cisgender men, and trans and non-binary people, was shown to reduce the risk of HIV by 96%.  LEN now enters a select category, one of five ARV-based options for PrEP that all protect against HIV if you take them.  But many of the people applauding the results from PURPOSE 1 and 2 will tell you that breakthrough science like this is, as hard as it is, is still the easy part. To break the back of the HIV epidemic demands overcoming an altogether different challenge—coordinating and accelerating every step in rolling out new products so that everyone who needs HIV prevention can get it.    Listen to this podcast to learn what must be done to finally deliver on the promise of highly effective HIV prevention, from pills to rings to injectable PrEP and beyond.   Resources  Second Pivotal Trial of Twice-Yearly HIV Prevention Injection Safe and Highly Effective: PURPOSE 2 Trial Among Gay Men, Trans and Nonbinary People, AVAC Press Release  The Lens on LEN: The basics on injectable lenacapavir as PrEP, AVAC  Country planning matrix, PrEPWatch  Moving a Product to the Real World, AVAC  The long wait for long-acting HIV prevention and treatment formulations, Lancet  A game-changer for PrEP if access is adequate, Lancet  Allocation of Non-Commercial CAB for PrEP Supply in Low- and Middle-Income Countries, 2023-2025, AVAC  Generic Cabotegravir Timelines, AVAC  UNAIDS Exec Summary, UNAIDS  Lenacapavir: What it would it take to get the 6-monthly anti-HIV jab to SA, Bhekisisa 

In this insightful episode, Daniel and Garet sit down with Dan Harry, star of I Kissed a Boy and a powerful voice in HIV and sexual health advocacy. Dan opens up about his experience on the UK's first gay dating show, shedding light on the pressures of on-screen dating and the vulnerability that comes with reality TV. Beyond the entertainment world, Dan is making a significant impact in the LGBTQ+ community by participating in an HIV vaccine trial and hosting the BBC documentary HIV, PrEP & Me. Together, they explore the evolving conversations around HIV prevention, the importance of breaking down stigma, and how the gay community can prioritize sexual health. Dan's candidness about his personal struggles in dating, public perception, and advocacy work makes this a must-listen for anyone interested in both love and community activism. Key Highlights:Dan's Reality TV Experience: Dan talks about his unexpected journey on I Kissed a Boy and how joining later in the show impacted his confidence and connections.HIV Advocacy and PrEP: Dan discusses his role in an HIV vaccine trial and his BBC documentary, highlighting the importance of PrEP and HIV prevention education.Breaking Stigma: The conversation dives deep into how HIV stigma still exists and why it's essential to dismantle it, especially in the LGBTQ+ dating world.Dating in the Spotlight: Dan shares how being on reality TV has changed his dating life and the toxic traits he's working to overcome.Words of Wisdom: Dan reflects on how what may be seen as weaknesses can be our greatest strengths, offering empowering advice for those navigating the dating world. ___SUPPORT THE SHOW ON PATREONJoin our Patreon! Get access to deeper dives and juicier content around every episode! Move into the Modern Gayborhood for only $5 USD/month and help us produce Modern Gays. Your support pays for our hosting, audio production and episode research. Please check it out and sign up here!What's included:Exclusive content, stories and behind-the-scenesCommunity chats with Daniel and GaretExclusive voting power on episode topics/guestsDaniel and Garet's personal journal updates___SUBSCRIBE & REVIEW:Modern Gays is published every week. If you love the show and can support us, please subscribe and write a review wherever you get your podcasts! Thanks for listening! Daniel and GaretCo-Hosts of Modern Gayshttps://www.moderngays.co

“This podcast discusses the recent presentation of data for lenacapavir, a potent capsid inhibitor for HIV that was 100% effective in preventing HIV infection in cis-gender woman at risk for HIV. If approved, it will offer an exciting new option to prevent HIV which should dramatically improve our chances of reaching the goal of totally eliminating new HIV infections.  The trial compared twice yearly injections of lenacapavir to both F/TAF and F/TDF in cis-gender woman and found similar effectiveness for F/TAF compared to F/TDF but there were zero new HIV infections in participants on lenacapavir.”. Related Content:  The New England Journal of Medicine. Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women. Authors: Linda-Gail Bekker, M.B., Ch.B, Ph.D. https://orcid.org/0000-0002-0755-4386, Moupali Das, M.D., M.P.H., Quarraisha Abdool Karim, Ph.D. https://orcid.org/0000-0002-0985-477X, Khatija Ahmed, M.B., B.Ch., Joanne Batting, M.B., Ch.B., D.F.S.R.H., D.R.C.O.G., Dip. HIV Man., William Brumskine, M.B., Ch.B., Dip. HIV Man., Katherine Gill, M.B., Ch.B., M.P.H., +33, for the PURPOSE 1 Study Team*Author Info & Affiliations. Published July 24, 2024. DOI: 10.1056/NEJMoa2407001 CEI toll free line for NYS providers: 866-637-2342 https://ceitraining.org/

About this episode: Now in its 21st year, PEPFAR—the President's Emergency Plan for AIDS Relief which launched in 2003 under President George W. Bush—still has ending the HIV epidemic in its sights. It's now at a critical juncture with an expanding toolbox of exciting treatments and, simultaneously, eroding bipartisan support from Congress. Guest: Dr. Mike Reid is the Chief Science Officer in the U.S. Department of State's Bureau of Global Health Security and Diplomacy. Host: Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women—The New England Journal of Medicine Why The World's Most Lifesaving AIDS Program is in Danger—Public Health On Call podcast (December, 2023) A Conversation With The Experts on Ending The HIV Epidemic—Johns Hopkins Bloomberg School of Public Health Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on X @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed

Wednesday, August 7th 2024Today, Kamala Harris has chosen Minnesota Governor Tim Walz as her vice presidential running mate; Republican Representative Andy Ogles has been hit with an FBI search warrant; the en banc Fourth Circuit Court of Appeals upholds Maryland's assault weapons ban; now the North Carolina election board is investigating Elon Musk's pro-Trump PAC after a voter data complaint; Donald hikes his Mar-a-Lago membership to $1m, raising concerns of selling access; union workers at Crooked Media stage a walkout to protest ‘anti-union negotiating tactics'; plus Allison and Dana deliver your Good News.Promo Code:For a limited time, HomeChef is offering you 18 Free Meals, plus Free Shipping on your first box, and Free Dessert for Life. At https://www.HomeChef.com/DAILYBEANS.Our GuestsRick Smiththericksmithshow.comThe Rick Smith Show (freespeech.org)twitter.com/RickSmithShowThe Rick Smith Show Podcast (Apple Podcasts)Dave Aronberghttps://twitter.com/aronberghttps://www.youtube.com/@TrueCrimeMTNhttps://linktr.ee/davearonbergStoriesFBI agents execute search warrant on Tennessee Congressman Andy Ogles, NewsChannel 5 confirms (NewsChannel5 Nashville)North Carolina election board investigates Elon Musk's pro-Trump PAC after voter data complaint (CNBC)Trump hikes Mar-a-Lago membership to $1m, raising concerns of selling access (The Guardian)Workers at ‘Pod Save America' Producer Crooked Media Stage Walkout to Protest Alleged ‘Anti-Union Negotiating Tactics' (Variety)Give to the Kamala Harris Presidential CampaignKamala Harris (MSW Media Donation Link) — Donate via ActBlueCheck out other MSW Media podcastshttps://mswmedia.com/shows/Subscribe to Lawyers, Guns, And MoneyAd-free premium feed: https://lawyersgunsandmoney.supercast.comSubscribe for free everywhere else:https://lawyersgunsandmoney.simplecast.com/episodes/1-miami-1985Subscribe for free to MuellerSheWrote on Substackhttps://muellershewrote.substack.comFollow AG and Dana on Social MediaDr. Allison Gill Follow Mueller, She Wrote on Posthttps://post.news/@/MuellerSheWrote?utm_source=TwitterAG&utm_medium=creator_organic&utm_campaign=muellershewrote&utm_content=FollowMehttps://muellershewrote.substack.comhttps://twitter.com/MuellerSheWrotehttps://www.threads.net/@muellershewrotehttps://www.tiktok.com/@muellershewrotehttps://instagram.com/muellershewroteDana Goldberghttps://twitter.com/DGComedyhttps://www.instagram.com/dgcomedyhttps://www.facebook.com/dgcomedyhttps://danagoldberg.comHave some good news; a confession; or a correction to share?Good News & Confessions - The Daily Beanshttps://www.dailybeanspod.com/confessional/From The Good NewsKamala Harris (MSW Media Donation Link) — Donate via ActBlueAntiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women (the New England Journal of Medicine)www.nanustudio.coinstagram.com/nanustudiocoCheck Your Voter Registration!! (Vote.org) Live Show Ticket Links:https://allisongill.com (for all tickets and show dates)Friday August 16th Washington, DC - with Andy McCabe, Pete Strzok, Glenn Kirschner https://tinyurl.com/Beans-in-DCSaturday August 24 San Francisco, CA https://tinyurl.com/Beans-SF Listener Survey:http://survey.podtrac.com/start-survey.aspx?pubid=BffJOlI7qQcF&ver=shortFollow the Podcast on Apple:The Daily Beans on Apple PodcastsWant to support the show and get it ad-free and early?Supercasthttps://dailybeans.supercast.com/OrPatreon https://patreon.com/thedailybeansOr subscribe on Apple Podcasts with our affiliate linkThe Daily Beans on Apple Podcasts

On episode #60 of the Infectious Disease Puscast, Daniel and Sara review the infectious disease literature for the weeks of 7/18/20 – 7/31/24. Host: Daniel Griffin and Sara Dong Subscribe (free): Apple Podcasts, RSS, email Become a patron of Puscast! Links for this episode Olympics Swimming in the Seine (NYTimes) Viral Twice-Yearlylenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women (NEJM) Consensus definitions of Cytomegalovirus Infection and Disease in Transplant Patients (CID) The recombinant shingles vaccine is associated with lower risk of dementia (Nature Medicine) Association of the incidence of postherpetic neuralgia with early treatment intervention of herpes zoster (International Journal of Infectious Diseases) Bacterial Updated guidelines for antimicrobial resistant gram-negative infections (IDSA) Put the Vanc Down, Flip it and Reverse it: Comparison of vancomycin and daptomycin (OFID) Durations of antibiotic treatment for acute otitis media and variability in prescribed durations (Journal of Pediatric Infectious Diseases Society) Fungal Adjunctive single-dose liposomal amphotericin to prevent cryptococcal meningitis in people with human immunodeficiency virus (HIV)–associated cryptococcal antigenemia and low plasma cryptococcal antigen (CrAg) titers(CID) Stagonospora cutaneous infection in a kidney transplant recipient: First human case (Transplant Infectious Disease) European Study of cerebral aspergillosis treated with Isavuconazole: an EFISG study (CID) Parasitic Rollout of world's second malaria vaccine begins in Ivory Coast (Healio) Executive summary: Evaluation and management of delusional infestation(CID) Parasitic contamination of soil in the Southern United States (ASTMH) Miscellaneous The potential benefits of delaying seasonal influenza vaccine selections for the northern hemisphere: A retrospective modeling study in the United States (JID) Music is by Ronald Jenkees

Broadcast from KSQD, Santa Cruz on 8-01-2024: Dr. Dawn discusses the American Endocrine society's recent guidelines on vitamin D testing and supplementation, explaining its importance for various age groups and health conditions. She clarifies misconceptions about vitamin D toxicity and emphasizes the need for proper dosing. The show addresses a listener's question about dealing with reflux many hours after his last meal, explaining the circadian rhythm of gastric acid secretion and offering practical advice for managing symptoms. Dr. Dawn talks about a new comprehensive glycemic index and glycemic load of foods derived with AI-assistance. She highlights the impact of high glycemic foods on blood sugar and appetite. A recent study on fish oil supplements and brain function in older adults is discussed, showing significant benefits for those with the Alzheimer's-associated APOE4 gene in reducing white matter lesions in as little as one year. A listener inquires about stem cell injections. Dr. Dawn then covers the dangers of unregulated stem cell treatments, warning listeners about the lack of oversight and potential risks associated with these therapies. Dr. Dawn explains the concept of cryptic pregnancy, where women are unaware of their pregnancy until labor begins, discussing potential causes and occurrences. The show delves into the issue of healthcare monopolies, focusing on UnitedHealth Group and other large healthcare corporations. Dr. Dawn explains how these monopolies impact patient care, costs, and physician autonomy. A study on walking as a treatment for back pain is presented, showing significant benefits for those who follow a regular walking regimen in reducing pain flare-ups and extending pain-free periods. The program concludes with news about a new HIV antiviral drug administered by injection every six months, demonstrating high efficacy in preventing HIV infection among high-risk populations.

Can a twice-yearly shot provide 100% protection against HIV? Find out about this and more in today's PeerDirect Medical News Podcast.

Thursday, July 25th 2024Today, the Democratic National Convention Rules Committee has passed a nomination process proposal; Vote.org has announced a 700% increase in daily voter registrations in the past 48 hours; the Harris Campaign has added Pete Buttegieg to the list of VP candidates they're considering; FBI Director Chris Wray tells Congress it's not clear whether Trump was hit by a bullet or shrapnel; the Citizens Redistricting Commission proposal has qualified for the November ballot in Ohio; Elon Musk has canceled his $45M per month contribution to Donald Trump as Tesla profit tanks by 45%; experts say a twice-yearly injection that offers 100% protection against HIV is ‘stunning'; plus Allison and Dana deliver your Good News.Answer The Call! Thursday, July 25 8:30pmhttps://twitter.com/shannonrwattsStoriesDemocrats poised to virtually nominate Harris — and her running mate — by Aug. 7 (AP News)Surprise: Elon Musk Says He Isn't Actually Donating $45 Million a Month to Trump (Vanity Fair)Proposal to create a new political mapmaking system in Ohio qualifies for November ballot (AP News)Experts say a twice-yearly injection that offers 100% protection against HIV is ‘stunning' (AP News)Check out other MSW Media podcastshttps://mswmedia.com/shows/Subscribe to Lawyers, Guns, And MoneyAd-free premium feed: https://lawyersgunsandmoney.supercast.comSubscribe for free everywhere else:https://lawyersgunsandmoney.simplecast.com/episodes/1-miami-1985Subscribe for free to MuellerSheWrote on Substackhttps://muellershewrote.substack.comFollow AG and Dana on Social MediaDr. Allison Gill Follow Mueller, She Wrote on Posthttps://post.news/@/MuellerSheWrote?utm_source=TwitterAG&utm_medium=creator_organic&utm_campaign=muellershewrote&utm_content=FollowMehttps://muellershewrote.substack.comhttps://twitter.com/MuellerSheWrotehttps://www.threads.net/@muellershewrotehttps://www.tiktok.com/@muellershewrotehttps://instagram.com/muellershewroteDana Goldberghttps://twitter.com/DGComedyhttps://www.instagram.com/dgcomedyhttps://www.facebook.com/dgcomedyhttps://danagoldberg.comHave some good news; a confession; or a correction to share?Good News & Confessions - The Daily Beanshttps://www.dailybeanspod.com/confessional/From The Good NewsSharon McMahon's substack, The PreambleHopium Chronicles By Simon Rosenberg | SubstackCoyote and Crow Tabletop game (coyoteandcrow.net)https://curectnnb1.orghttps://ctnnb1-foundation.org Live Show Ticket Links:https://allisongill.com (for all tickets and show dates)Friday August 16th Washington, DC - with Andy McCabe, Pete Strzok, Glenn Kirschner https://tinyurl.com/Beans-in-DCSaturday August 24 San Francisco, CA https://tinyurl.com/Beans-SF Listener Survey:http://survey.podtrac.com/start-survey.aspx?pubid=BffJOlI7qQcF&ver=shortFollow the Podcast on Apple:The Daily Beans on Apple PodcastsWant to support the show and get it ad-free and early?Supercasthttps://dailybeans.supercast.com/OrPatreon https://patreon.com/thedailybeansOr subscribe on Apple Podcasts with our affiliate linkThe Daily Beans on Apple Podcasts

In this episode of Going anti-Viral, Dr Michael Saag speaks with Dr Raphael Landovitz from the UCLA Medical School about the latest information on HIV prevention via Preexposure Prophylaxis, or PrEP. They discuss the history of PrEP and early efficacy and then move into a discussion of the evolution of PrEP from episodic dosing to longer-acting therapies. The episode also highlights recent research and how that may impact the future of PrEP dosing.0:00 - Introduction1:59 - History of Preexposure Prophylaxis, or PrEP 5:39 - Why initial PrEP regimens were not 100% effective12:01 - Discussion of episodic PrEP and 2-1-1 regimens16:22 - How longer-acting therapy has been shown to be superior to episodic dosing20:29 - LEVI syndrome - what is it?25:05 - What the future holds for PrEP 29:18 - Closing Remarks __________________________________________________Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections. Going anti-Viral's host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences. Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode.Follow Going anti-Viral on: Apple Podcasts YouTube InstagramTikTok...

Robot Suicide; News Items: Mars Settlement Simulation, HIV Prevention, COVID Protection Gene, Nuclear Pasta, Eyeball Planet; Who's That Noisy; Your Questions and E-mails: Hydrogen Water; Science or Fiction

According to the CDC, out of 31,000 new HIV infections in the U.S, almost 20% were women. If we want to end the epidemic, say infection disease experts, at least 50% of people at high risk for contracting HIV need to be on pre-exposure prophylaxis medicine (PrEP). At the moment, 92% of those on PrEP are men and only 8% are women—so clearly our efforts to connect with women are falling short. What are the barriers and challenges women face in getting information and treatment? Two renowned leaders in the field say we need to think outside the box to meet women where they are. This podcast is not available for CME/CE/CPD credits. Please visit the Medscape homepage for accredited CME/CE/CPD activities.

In this episode, Roger Bedimo, MD, MS, FACP, discusses strategies to overcome health disparities to improve PrEP uptake, including:Targeting key populations that would benefit from PrEP but have low rates of uptake, such as transgender women and people who inject drugsAddressing intersectionalityOvercoming implicit biasAddressing PrEP inequity by geographic regionExpanding PrEP uptake by expanding HCPs who prescribe itImproving PrEP education for both patients and HCPsPresenter:Roger Bedimo, MD, MS, FACPProfessor of MedicineInterim Director, Office of Global HealthUT Southwestern Medical CenterChief, Infectious Diseases SectionVA North Texas Health Care SystemDallas, TexasContent based on an online CME program supported by an independent educational grant from ViiV Healthcare.Link to full program: https://bit.ly/49x0W6DFollow along with the slides: https://bit.ly/3KmW4pNGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

In this episode, Roger Bedimo, MD, MS, FACP, examines patient and regimen-based PrEP barriers and discusses practical interventions to support PrEP adherence in key populations. Topics covered include:Individual and community perspectives on PrEP barriersKey barriers by principal populationsStrategies to support PrEP deliveryPrEP options for key populationsPrEP efficacy based on adherence in cisgender men and womenComparing FTC/TDF vs FTC/TAF or CAB for PrEPPrEP in pregnancy and breastfeedingDrug–drug interactions with gender-affirming hormone therapyPresenter:Roger Bedimo, MD, MS, FACPProfessor of MedicineInterim Director, Office of Global HealthUT Southwestern Medical CenterChief, Infectious Diseases SectionVA North Texas Health Care SystemDallas, TexasContent based on an online CME program supported by an independent educational grant from ViiV Healthcare.Link to full program: https://bit.ly/49x0W6DFollow along with the slides: https://bit.ly/3KmW4pNGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

In this episode, Roger Bedimo, MD, MS, FACP, examines provider-based and structural PrEP barriers and discusses practical methods for healthcare professionals to overcome these challenges. Topics covered include:Potential provider barriers to prescribing PrEPStrategies to facilitate conversations about PrEPAddressing the gap in PrEP provider trainingStructural barriers for PrEP coverage, such as lack of insurance and complexity of billingInformed consent for minorsCDC guidelines on HIV testing and renal or lipid monitoring while on PrEPThe role of PrEP champions or PrEP navigators, such as in the SNAPS PrEP Navigation ProgramSolutions to common problems with PrEP persistence, such as use of telehealth and same-day PrEP initiationExpanding PrEP optionsPresenter:Roger Bedimo, MD, MS, FACPProfessor of MedicineInterim Director, Office of Global HealthUT Southwestern Medical CenterChief, Infectious Diseases SectionVA North Texas Health Care SystemDallas, TexasContent based on an online CME program supported by an independent educational grant from ViiV Healthcare.Link to full program: https://bit.ly/49x0W6DFollow along with the slides: https://bit.ly/3KmW4pNGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

Become a pro on pre-exposure prophylaxis! Review the updated 2023 United States Preventive Task Force (USPSTF) guidelines on PrEP for HIV Prevention with Dr. John Wong. Patreon | Episodes | Subscribe | Spotify | YouTube | Newsletter | Contact | Swag! | CME Show Segments Intro What is PrEP? USPSTF PrEP for HIV Prophylaxis recommendations Defining Increased Risk for HIV Counseling pearls Types of PrEP, considerations about choice of PrEP Talking about Safer Sex practices, HIV and STI screening on PrEP Recap; outro Credits Producer, Writer, Show Notes, Infographic/Cover Art: Beth Garbitelli MD Hosts: Paul Williams MD, FACP, Beth Garbitelli MD Reviewer:Leah Witt MD Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP Technical Production: PodPaste Guest: John Wong MD